Next week will see more than 150 companies from diverse sectors, including banking, pharmaceuticals, fintech, cement, and IT, ...

Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...

Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...

Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Passive Income Stocks to Buy Now. The company has been ...

Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation concerns. See more on CL stock here.

Colgate-Palmolive is set to announce its second-quarter results early next month, with analysts expecting a modest ...

Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.

The global Oral Care Market, valued at US$34.97 billion in 2024 stood at US$37.21 billion in 2025 and is projected to advance ...

Colgate-Palmolive’s chief executive recently signaled he would be open to selling the company — which has grappled with sluggish demand for its toothpaste, deodorants and food products — for ...

Colgate-Palmolive’s (NYSE: CL) stock has gone from $67.42 in November 2016 to $66.52 in November 2019. Over this period there has been a ~3% rise in total revenue and an equal drop in number of ...